[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Indexing Sources::
Editorial Board::
Executive Members::
Articles Archive::
Instruction to Authors::
Peer-Review::
Contact Us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 20, Issue 1 (3-2018) ::
J Gorgan Univ Med Sci 2018, 20(1): 90-95 Back to browse issues page
Frequncey of PDCD1.3 gene polymorphisms in systemic lupus erythematosus patients
Yousef Khanjari1 , Alijan Tabarraei 2, Morteza Oladnabi3 , Nafiseh Abdolahi4
1- M.Sc in Virology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
2- Associate Professor, Infectious Diseases Research Center, Golestan University of Medical Sciences, Gorgan, Iran. tabarraei@goums.ac.ir , tabarraei@goums.ac.ir
3- Assistant Professor, Gorgan Congenital Malformations Research Center, Department of Human Genetics, School of Advanced Technologies in Medicine, Golestan University of Medical Sciences, Gorgan, Iran
4- Assistant Professor, Rheumatology Research Center, Golestan University of Medical Sciences, Gorgan, Iran
Abstract:   (15279 Views)
Background and Objective: Single Nucleotide Polymorphisms in programmed cell death which expressed at high level in T cells, plays an important role in the development and cause autoimmune disorders. This study was done to evaluate the frequncy of rs11568821 polymorphism in patients with systemic lupus erythematosus (SLE).
Methods: This case-control study was done on 76 patients with SLE and 56 healthy controls. After DNA extraction, frequncy of polymorphisms PDCD1.3 by polymerase chain reaction and sequencing methods in subjects were determined.
Results: There was a significant diference between frequency of allele and genotype at rs11568821 Polymorphism in region of intron 4 of PDCD1.3 gene in case and control groups (P<0.05). A allele and AG genotype was significantly higher in patients than healthy controls (9.5% vs 0.09%, P<0.05). There was no significant association between clinical and laboratory findings with genotype frequencies.
Conclusion: rs11568821 single nucleotide polymorphism in intron 4 gene region PDCD1 can be used as a genetic factor to be involved the SLE susceptibility.
Keywords: Systemic lupus erythematosus, PDCD1.3, Sequencing methods, Single Nucleotide Polymorphisms, Polymerase chain reaction
Full-Text [PDF 266 kb] [English Abstract]   (9093 Downloads) |   |   Abstract (HTML)  (542 Views)  
Type of Study: Original Articles | Subject: Internal Medicine
References
1. Hannahs Hahn BH. Systemic Lupus Erythematosus. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison's Principles of Internal Medicine. Chap 319. 19th ed. New York: McGraw-Hill Education/Medical. 2015; pp: 2124-34.
2. Thorburn CM, Prokunina-Olsson L, Sterba KA, Lum RF, Seldin MF, Alarcon-Riquelme ME, et al. Association of PDCD1 genetic variation with risk and clinical manifestations of systemic lupus erythematosus in a multiethnic cohort. Genes Immun. 2007 Jun; 8(4): 279–87. doi:10.1038/sj.gene.6364383
3. Akbarian M, Faezi ST, Gharibdoost F, Shahram F, Naji AH, Jamshidi AR, et al. [The epidemiology of systemic lupus erythematosus in Iran: a survey on 2143 cases]. Tehran Univ Med J. 2010; 68(5): 300-305. [Article in Persian]
4. Liu JL, Zhang FY, Liang YH, Xiao FL, Zhang SQ, Cheng YL, et al. Association between the PD1.3A/G polymorphism of the PDCD1 gene and systemic lupus erythematosus in European populations: a meta-analysis. J Eur Acad Dermatol Venereol. 2009 Apr; 23(4): 425-32. doi:10.1111/j.1468-3083.2009.03087.x
5. O'Neill S, Cervera R. Systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2010 Dec; 24(6): 841-55. doi:10.1016/j.berh.2010.10.006
6. Alavi SM, Moola K. [Tuberculosis specificity characteristics among febrile patients with systemic lupus erythematosus on steroid therapy]. J Gorgan Univ Med Sci. 2010; 12(3): 79-83. [Article in Persian]
7. Gianchecchi E, Delfino DV, Fierabracci A. Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity. Autoimmun Rev. 2013 Sep; 12(11): 1091-100. doi:10.1016/j.autrev.2013.05.003
8. Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol. 2008; 26:677-704. doi:10.1146/annurev.immunol.26.021607.090331
9. Lv F, Gao YF, Zhang ZH, Zhang TC, Pan FM, Cui MF, et al. Polymorphisms in programmed death-1 gene are not associated with chronic HBV infection in Chinese patients. World J Hepatol. 2011 Mar; 3(3):72-8. doi:10.4254/wjh.v3.i3.72
10. Okazaki T, Honjo T. PD-1 and PD-1 ligands: from discovery to clinical application. Int Immunol. 2007 Jul; 19(7): 813-24. doi:10.1093/intimm/dxm057
11. Shadmehri AA, Nicknam MH, Shokrgozar MA, Mahmoudi M, Sarial Sh, Ahmadi Shadmehri A, et al. Assessment of PD-1 gene variation in patients with multiple sclerosis. Tehran Univ Med J. 2010; 68(2): 87-93.
12. Soleimanifar N, Amirzargar AA, Mahmoudi M, Pourfathollah AA, Azizi E, Jamshidi AR, et al. Study of programmed cell death 1 (PDCD1) gene polymorphims in Iranian patients with ankylosing spondylitis. Inflammation. 2011 Dec; 34(6):707-12. doi:10.1007/s10753-010-9282-4
13. Zheng L, Li D, Wang F, Wu H, Li X, Fu J, et al. Association between hepatitis B viral burden in chronic infection and a functional single nucleotide polymorphism of the PDCD1 gene. J Clin Immunol. 2010 Nov;30(6):855-60. doi:10.1007/s10875-010-9450-1
14. Prokunina L, Gunnarsson I, Sturfelt G, Truedsson L, Seligman VA, Olson JL, et al. The systemic lupus erythematosus-associated PDCD1 polymorphism PD1.3A in lupus nephritis. Arthritis Rheum. 2004 Jan;50(1):327-8. doi:10.1002/art.11442
15. Johansson M, Arlestig L, Möller B, Rantapää-Dahlqvist S. Association of a PDCD1 polymorphism with renal manifestations in systemic lupus erythematosus. Arthritis Rheum. 2005 Jun;52(6):1665-9. doi:10.1002/art.21058
16. Sanghera DK, Manzi S, Bontempo F, Nestlerode C, Kamboh MI. Role of an intronic polymorphism in the PDCD1 gene with the risk of sporadic systemic lupus erythematosus and the occurrence of antiphospholipid antibodies. Hum Genet. 2004 Oct;115(5):393-8. doi:10.1007/s00439-004-1172-0
17. Chen S, Li Y, Deng C, Li J, Wen X, Wu Z, et al. The associations between PD-1, CTLA-4 gene polymorphisms and susceptibility to ankylosing spondylitis: a meta-analysis and systemic review. Rheumatol Int. 2016 Jan;36(1):33-44. doi:10.1007/s00296-015-3327-9
18. Prokunina L, Castillejo-López C, Oberg F, Gunnarsson I, Berg L, Magnusson V, et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet. 2002 Dec;32(4):666-9. doi:10.1038/ng1020
19. Canto LM, Farias TD, Medeiros MD, Coêlho CC, Sereia AF, Back LK, et al. Association of PDCD1 polymorphism to Systemic Lupus Erythematosus and Rheumatoid Arthritis susceptibility. Rev Bras Reumatol. 2015 Jul; pii: S0482-5004(15)00071-6. [Article in English, Portuguese] doi:10.1016/j.rbr.2015.05.001
20. Chua KH, Lian LH, Sim XJ, Cheah TE, Lau TP. Association between PDCD1 Gene Polymorphisms and Risk of Systemic Lupus Erythematosus in Three Main Ethnic Groups of the Malaysian Population. Int J Mol Sci. 2015 May; 16(5): 9794-803. doi:10.3390/ijms16059794
21. Lee YH, Bae SC, Kim JH, Song GG. Meta-analysis of genetic polymorphisms in programmed cell death 1. Associations with rheumatoid arthritis, ankylosing spondylitis, and type 1 diabetes susceptibility. Z Rheumatol. 2015 Apr; 74(3):230-9. doi:10.1007/s00393-014-1415-y
22. Xiao W, Zhang Q, Deng XZ, Jiang LF, Zhu DY, Pei JP, et al. Genetic variations of IL-28B and PD-1 are in association with the susceptibility and outcomes of HCV infection in Southeast China. Infect Genet Evol. 2015 Jun;32:89-96. doi:10.1016/j.meegid.2015.02.022
23. Nasi M, Riva A, Borghi V, D'Amico R, Del Giovane C, Casoli C, et al. Novel genetic association of TNF--238 and PDCD1-7209 polymorphisms with long-term non-progressive HIV-1 infection. Int J Infect Dis. 2013 Oct; 17(10):e845-50. doi:10.1016/j.ijid.2013.01.003
24. Chua KH, Lian LH, Sim XJ, Cheah TE, Lau TP. Association between PDCD1 Gene Polymorphisms and Risk of Systemic Lupus Erythematosus in Three Main Ethnic Groups of the Malaysian Population. Int J Mol Sci. 2015 Apr; 16(5): 9794-803. doi:10.3390/ijms16059794
25. Mahmoudi M, Rezaiemanesh A, Salmaninejad A, Harsini S, Poursani S, Bahrami T, et al. PDCD1 single nucleotide genes polymorphisms confer susceptibility to juvenile-onset systemic lupus erythematosus. Autoimmunity. 2015;48(7):488-93. doi:10.3109/08916934.2015.1058370
26. Molina JF, Molina J, García C, Gharavi AE, Wilson WA, Espinoza LR. Ethnic differences in the clinical expression of systemic lupus erythematosus: a comparative study between African-Americans and Latin Americans. Lupus. 1997;6(1):63-7.
Send email to the article author


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khanjari Y, Tabarraei A, Oladnabi M, Abdolahi N. Frequncey of PDCD1.3 gene polymorphisms in systemic lupus erythematosus patients . J Gorgan Univ Med Sci 2018; 20 (1) :90-95
URL: http://goums.ac.ir/journal/article-1-3283-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 20, Issue 1 (3-2018) Back to browse issues page
مجله دانشگاه علوم پزشکی گرگان Journal of Gorgan University of Medical Sciences
Persian site map - English site map - Created in 0.04 seconds with 36 queries by YEKTAWEB 4645